摘要
药品费用共付是各类健康保险计划最为常用的需方控制措施 ,适宜的共付水平以及对弱势人群的合理保护是其主要关注之所在。保险药品参考定价广义上也属于需方控制机制 ,其适宜性与有效性取决于医疗服务体系与药品市场价格状况 。
Co-payment is the common used measure of pharmaceutical expenditures consumer containment in all health plans, where appropriate co-payment level and proper protection for the vulnerable are concerned. In general, reference pricing is also one of the expenditure containment mechanisms aiming at consumers, the appropriateness and validity of which depends on healthcare system and pharmaceutical price situations and is associated with other coordinated measures.
出处
《中国卫生资源》
2004年第1期39-42,共4页
Chinese Health Resources